WE
ANGO icon

Wealth Effects’s AngioDynamics ANGO Stock Holding History

Wealth Effects’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+17,350
New +$197K 0.06% 224

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Effects's ANGO Position: Q2 2026 in Review

Wealth Effects opened a new position in AngioDynamics (ANGO) in Q2 2026: 17,350 shares worth $226K. The stake represents 0.06% of the portfolio and ranks #224 among its holdings.

162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Wealth Effects held 17,350 shares of AngioDynamics worth $226K as of Q2 2026.
  • AngioDynamics was a new Wealth Effects position in Q2 2026.
  • AngioDynamics made up 0.06% of Wealth Effects's portfolio in Q2 2026, its #224 holding.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.